Anna Eramo

Qualify: a randomized head-to-head study of aripiprazole once-monthly and paliperidone palmitate in the treatment of schizophrenia

Dieter Naber, Karina Hansen, Carlos Forray et al. · Schizophrenia Research · 2015 · 156 citations · Full text

Aripiprazole once-monthly for treatment of schizophrenia: double-blind, randomised, non-inferiority study

W. Wolfgang Fleischhacker, Raymond Sanchez, Pamela Perry et al. · The British Journal of Psychiatry · 2014 · 151 citations · Full text

Aripiprazole Once-Monthly in the Acute Treatment of Schizophrenia

John M. Kane, Timothy Peters-Strickland, Ross A. Baker et al. · The Journal of Clinical Psychiatry · 2014 · 103 citations · Full text

Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: Role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis

Andrea de Bartolomeis, Chiara Sarappa, Elisabetta Filomena Buonaguro et al. · Progress in Neuro-Psychopharmacology and Biological Psychiatry · 2013 · 69 citations

Neuropsychology, Psychiatry, Neurophysiology +12

Hospitalisation rates in patients switched from oral anti-psychotics to aripiprazole once-monthly for the management of schizophrenia

John M. Kane, Raymond Sanchez, Joan Zhao et al. · Journal of Medical Economics · 2013 · 48 citations · Full text